首页> 外文OA文献 >Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood
【2h】

Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood

机译:原始造血祖细胞的多谱系扩增潜能:脐血与动员外周血相比的优越性

摘要

OBJECTIVE: The majority of studies assessing ex-vivo expansion of primitive hematopoietic cells only address production of myeloid progeny whereas it may be more appropriate to maintain or expand progenitors that retain capacity for multilineage differentiation. In this study, we assessed the capacity of the murine fetal liver cell line AFT024 to expand primitive myeloid progenitors (LTC-IC) and lymphoid progenitors (NK-IC) from umbilical cord blood (CB) and mobilized peripheral blood (PB) CD34(+)lin(-)38(-) cells. METHODS: Sorted cells were established in expansion cultures in direct contact with the feeder or in a transwell above the feeder (noncontact culture) and various combinations of Flt-3L (FL), stem cell factor, interleukin 7, thrombopoietin (Tpo), and macrophage inflammatory protein-1alpha added. Frequency of LTC-IC and NK-IC was assessed at day 0 and following 2 and 5 weeks expansion culture. RESULTS: CB contained significantly more LTC-IC and NK-IC at day 0 and showed an enhanced capacity for expansion compared to PB. The combination of FL and Tpo showed maximal expansion of CB LTC-IC and NK-IC at 5 weeks in both contact and noncontact conditions. In contrast, expansion of PB LTC-IC and NK-IC was maximal at 2 weeks and required multiple cytokines. CONCLUSIONS: These results demonstrate that AFT024 can expand primitive hematopoietic progenitors from CB and PB and expanded cells retain the capacity for myeloid and lymphoid differentiation. These findings emphasize the importance of assessing multi-lineage differentiation capacity following ex-vivo expansion. Elucidation of specific factors necessary for ex-vivo expansion will contribute to the development of a clinically applicable system.
机译:目的:大多数评估原始造血细胞体外扩增的研究仅针对骨髓后代的产生,而维持或扩增保留多系分化能力的祖细胞可能更合适。在这项研究中,我们评估了鼠胎儿肝细胞系AFT024从脐带血(CB)和动员的外周血(PB)CD34()扩增原始髓样祖细胞(LTC-IC)和淋巴样祖细胞(NK-IC)的能力。 +)lin(-)38(-)细胞。方法:在与饲养层直接接触或在饲养层上方的transwell(非接触培养)以及Flt-3L(FL),干细胞因子,白介素7,血小板生成素(Tpo)和添加了巨噬细胞炎性蛋白1alpha。 LTC-IC和NK-IC的频率在第0天以及扩增后2和5周评估。结果:与PB相比,CB在第0天包含更多的LTC-IC和NK-IC,并且显示出增强的扩张能力。 FL和Tpo的组合显示在接触和非接触条件下5周时CB LTC-IC和NK-IC的最大膨胀。相反,PB LTC-IC和NK-IC的扩增在2周时最大,需要多种细胞因子。结论:这些结果表明,AFT024可以从CB和PB扩增原始的造血祖细胞,并且扩增的细胞保留了髓样和淋巴样分化的能力。这些发现强调了体外扩增后评估多系分化能力的重要性。阐明离体扩增所需的特定因素将有助于临床应用系统的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号